MRMD
MariMed Inc

3,739
Loading...
Loading...
News
all
press releases
MariMed Inc. (MRMD) Upgraded to Strong Buy: What Does It Mean for the Stock?
MariMed Inc. (MRMD) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks·2d ago
News Placeholder
More News
News Placeholder
Fast-paced Momentum Stock MariMed Inc. (MRMD) Is Still Trading at a Bargain
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, MariMed Inc. (MRMD) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Zacks·18d ago
News Placeholder
Why Fast-paced Mover MariMed Inc. (MRMD) Is a Great Choice for Value Investors
MariMed Inc. (MRMD) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Zacks·1mo ago
News Placeholder
Zacks Industry Outlook Highlights Envista, BioLife Solutions, InfuSystems and MariMed
Despite industry headwinds, Envista, BioLife Solutions, InfuSystems and MariMed are leveraging innovation and strategy for growth.
Zacks·2mo ago
News Placeholder
Despite Fast-paced Momentum, MariMed Inc. (MRMD) Is Still a Bargain Stock
MariMed Inc. (MRMD) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Zacks·2mo ago
News Placeholder
4 Medical Product Stocks to Watch From a Challenging Industry
The Zacks Medical products industry sees steady demand, but tariffs & policy headwinds keep growth under pressure in 2025. NVST, BLFS, INFU and MRMD reflect the favorable fundamentals.
Zacks·2mo ago
News Placeholder
MariMed Inc. (MRMD) Reports Break-Even Earnings for Q2
MariMed Inc. (MRMD) delivered earnings and revenue surprises of +100.00% and -2.91%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago

Latest MRMD News

View

Advertisement|Remove ads.

Advertisement|Remove ads.